Cargando…

Targeting LIM kinases in taxane resistant tumors

Detalles Bibliográficos
Autores principales:	Prunier, Chloé, Kapur, Reuben, Lafanechère, Laurence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239435/ https://www.ncbi.nlm.nih.gov/pubmed/27463010 http://dx.doi.org/10.18632/oncotarget.10816

Ejemplares similares

LIM kinases: cofilin and beyond
por: Prunier, Chloé, et al.
Publicado: (2017)

A quantitative proteomic analysis of cofilin phosphorylation in myeloid cells and its modulation using the LIM kinase inhibitor Pyr1
por: Prudent, Renaud, et al.
Publicado: (2018)

The Role of LIM Kinases during Development: A Lens to Get a Glimpse of Their Implication in Pathologies
por: Ribba, Anne-Sophie, et al.
Publicado: (2022)

Targeting LIM kinase in cancer and neurofibromatosis
por: Rak, Roni, et al.
Publicado: (2014)

LIM Kinases: From Molecular to Pathological Features
por: Bénédetti, Hélène, et al.
Publicado: (2023)

Targeting Rho Associated Kinases in Leukemia and Myeloproliferative Neoplasms
por: Mali, Raghuveer Singh, et al.
Publicado: (2012)

ROCK1 via LIM kinase regulates growth, maturation and actin based functions in mast cells
por: Kapur, Reuben, et al.
Publicado: (2016)

Pyr1-Mediated Pharmacological Inhibition of LIM Kinase Restores Synaptic Plasticity and Normal Behavior in a Mouse Model of Schizophrenia
por: Gory-Fauré, Sylvie, et al.
Publicado: (2021)

LIM kinases in synaptic plasticity and their potential as therapeutic targets
por: Halász, Éva, et al.
Publicado: (2020)

LIM Kinases in Osteosarcoma Development
por: Brion, Régis, et al.
Publicado: (2021)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

P-gp and taxanes
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2014)

In the memory of Professor Felicidad Cua-Lim
por: Chang, Yoon-Seok
Publicado: (2014)

LIM Domain Kinases as Potential Therapeutic Targets for Neurofibromatosis Type 2
por: Petrilli, Alejandra, et al.
Publicado: (2013)

The Role of LIM Kinase in the Male Urogenital System
por: Park, Juhyun, et al.
Publicado: (2021)

LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells
por: Scott, Rebecca W., et al.
Publicado: (2010)

Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020)

LIM kinase 1 serves an important role in the multidrug resistance of osteosarcoma cells
por: Yang, Jian-Zeng, et al.
Publicado: (2018)

LIM Kinases, Promising but Reluctant Therapeutic Targets: Chemistry and Preclinical Validation In Vivo
por: Berabez, Rayan, et al.
Publicado: (2022)

Targeting SHP2 phosphatase in Myeloproliferative Neoplasms
por: Mali, Raghuveer Singh, et al.
Publicado: (2012)

LIM-Kinases in Synaptic Plasticity, Memory, and Brain Diseases
por: Ben Zablah, Youssif, et al.
Publicado: (2021)

LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation
por: Mardilovich, Katerina, et al.
Publicado: (2015)

The microtubule cytoskeleton: An old validated target for novel therapeutic drugs
por: Lafanechère, Laurence
Publicado: (2022)

CETSA-based target engagement of taxanes as biomarkers for efficacy and resistance
por: Langebäck, Anette, et al.
Publicado: (2019)

Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms
por: Pandey, Ruchi, et al.
Publicado: (2015)

Downregulation of LIM kinase 1 suppresses ocular inflammation and fibrosis
por: Gorovoy, Matvey, et al.
Publicado: (2008)

A role for cofilin and LIM kinase in Listeria-induced phagocytosis
por: Bierne, Hélène, et al.
Publicado: (2001)

Protein domain-based prediction of drug/compound–target interactions and experimental validation on LIM kinases
por: Doğan, Tunca, et al.
Publicado: (2021)

Inhibition of Mps1 kinase enhances taxanes efficacy in castration resistant prostate cancer
por: Sarwar, Sadia, et al.
Publicado: (2022)

Inhibition of the serine/threonine kinase BUB1 reverses taxane resistance in prostate cancer
por: Martinez, Maria J., et al.
Publicado: (2023)

MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells
por: Xu, Yongqian, et al.
Publicado: (2021)

Unique and redundant roles of class I(A) PI3Kinase regulatory subunits in mast cell development
por: Mali, Raghuveer Singh, et al.
Publicado: (2013)

Glutathione S-transferases (GSTs) polymorphism and taxane (docetaxel) sensitivity in breast cancer
por: Lee, Anbok
Publicado: (2019)

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
por: Giordano, Antonio, et al.
Publicado: (2019)

Damnacanthal, an effective inhibitor of LIM-kinase, inhibits cell migration and invasion
por: Ohashi, Kazumasa, et al.
Publicado: (2014)

Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle
por: Yu, Qingfeng, et al.
Publicado: (2021)

Analysis of the Drosophila Ajuba LIM protein defines functions for distinct LIM domains
por: Rauskolb, Cordelia, et al.
Publicado: (2022)

LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics
por: Geneste, Olivier, et al.
Publicado: (2002)

Involvement of LIM kinase 1 in actin polarization in human CD4 T cells
por: Xu, Xuehua, et al.
Publicado: (2012)

LIM kinase regulation of cytoskeletal dynamics is required for salivary gland branching morphogenesis
por: Ray, Shayoni, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u5au3vc6trd5rlj0uobvagnbsl